Kiniksa Pharmaceuticals Ltd (KNSA)
20.26
-0.06
(-0.32%)
USD |
NASDAQ |
May 08, 16:00
20.26
0.00 (0.00%)
After-Hours: 17:54
Kiniksa Pharmaceuticals Profit Margin (Quarterly): -22.17% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.17% |
| December 31, 2023 | 30.26% |
| September 30, 2023 | -20.66% |
| June 30, 2023 | 20.95% |
| March 31, 2023 | -25.38% |
| December 31, 2022 | 7.21% |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | -74.08% |
| March 31, 2022 | -78.32% |
| December 31, 2021 | -193.8% |
| September 30, 2021 | -252.5% |
| June 30, 2021 | -539.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-539.5%
Minimum
Jun 2021
30.26%
Maximum
Dec 2023
-104.4%
Average
-25.38%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -29.41% |
| Geron Corp | -18.22K% |
| United Therapeutics Corp | 45.24% |
| Vanda Pharmaceuticals Inc | -5.30% |
| TG Therapeutics Inc | -16.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.08% |
| Return on Assets | 1.76% |
| Return on Invested Capital | 2.08% |
| Gross Profit Margin (Quarterly) | 60.70% |
| Operating Margin (Quarterly) | -20.71% |
| Return on Net Operating Assets | 12.31% |